Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PAB12470 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#PAB12470, RRID:AB_10550712
- Product name
- BIRC5 polyclonal antibody
- Antibody type
- Polyclonal
- Description
- Rabbit polyclonal antibody raised against full length recombinant BIRC5.
- Storage
- Store at -20°C or -80°C.Aliquot to avoid repeated freezing and thawing.
Submitted references Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation.
Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistance.
BKM1740, an acyl-tyrosine bisphosphonate amide derivative, inhibits the bone metastatic growth of human prostate cancer cells by inducing apoptosis.
Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia.
Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis.
Lee JH, Palaia T, Ragolia L
American journal of physiology. Cell physiology 2009 Feb;296(2):C327-38
American journal of physiology. Cell physiology 2009 Feb;296(2):C327-38
Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistance.
Lu J, Tan M, Huang WC, Li P, Guo H, Tseng LM, Su XH, Yang WT, Treekitkarnmongkol W, Andreeff M, Symmans F, Yu D
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Feb 15;15(4):1326-34
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Feb 15;15(4):1326-34
BKM1740, an acyl-tyrosine bisphosphonate amide derivative, inhibits the bone metastatic growth of human prostate cancer cells by inducing apoptosis.
Seo SI, Gera L, Zhau HE, Qian WP, Iqbal S, Johnson NA, Zhang S, Zayzafoon M, Stewart J, Wang R, Chung LW, Wu D
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Oct 1;14(19):6198-206
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Oct 1;14(19):6198-206
Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia.
Zhang L, Murray F, Zahno A, Kanter JR, Chou D, Suda R, Fenlon M, Rassenti L, Cottam H, Kipps TJ, Insel PA
Proceedings of the National Academy of Sciences of the United States of America 2008 Dec 9;105(49):19532-7
Proceedings of the National Academy of Sciences of the United States of America 2008 Dec 9;105(49):19532-7
Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis.
Dai Y, Liu M, Tang W, DeSano J, Burstein E, Davis M, Pienta K, Lawrence T, Xu L
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Dec 1;14(23):7701-10
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Dec 1;14(23):7701-10
No comments: Submit comment
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Western blot analysis of BIRC5 in HeLa whole cell lysate (30 ug) using BIRC5 polyclonal antibody (Cat # PAB12470) at 1 ug/mL (1 minute exposure).
